[ Skip to main article on this page ]

Other languages: [ fr | de | es | it | pt | nl | ja | ko | zh | ar | cy ]

Welcome to Insulin Pumpers UK [Home] [This section: Experiences] [Advice] [UK issues] [Discussion groups] [Products] [Links] [About us]

[ What is an insulin pump? | Pros and cons of pumping | Just like wearing a yoyo | Not controlled, but in control! | Rewriting the diabetes rulebook | Insulin pump evaluation | Wearing the pump | Wearing a continuous glucose sensor | To pump or not to pump? | Pumps in pregnancy | Life on a pump | My perfect pump | Using the insulin pump during pregnancy | My pump | My CGMS test | A look back over year one | Diabetes UK Family Weekend | I want the best for my son | Active News - April 2002 | Finally got plugged in | Eleven months and counting | Back to injections | Using a DiaPort | An insulin pump for Sasha ]

advanced search


This page as a pdf file

Pros and cons of pumping

Discussion of the many advantages and disadvantages of insulin pump therapy

Using a pump is not all easy going. Diana Maynard examines some of the pros and cons of insulin pump therapy:

Advantages

Disadvantages


References

  1. I. Lager et al. Reversal of insulin resistance in Type 1 diabetes after treatment with continuous subcutaneous insulin infusion. BMJ 287: 1661-1663, 1983.
  2. H. Beck-Nielsen et al. Improved in vivo insulin effect during continuous subcutaneous insulin infusion in patients with IDDM. Diabetes 33: 832-837, 1984.
  3. C. Binder et al. Insulin pharmacokinetics. Diabetes Care 7:188-199, 1984.
  4. T. Lauritzen et al. Pharmacokinetics of continuous subcutaneous insulin infusion. Diabetologia 24: 326-329, 1983.
  5. E.A. Boland, M. Grey, A. Oesterle, L. Fredrickson, W.V. Tamborlane Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with Type 1 diabetes. Diabetes Care 22(11): 1779-84, 1999.
  6. K. Dahl-Jorgensen et al. Effect of near normoglycemia for two years on progression of early diabetic retinopathy, nephropathy and neuropathy: the Oslo study. BMJ 293: 1195-1201, 1986.
  7. J.J. Bending et al. Complications of insulin infusion pump therapy. JAMA 253: 2644, 1985.

Author: Diana Maynard <d.maynard@dcs.shef.ac.uk>. Diana Maynard is not a medical professional. She has Type 1 diabetes and uses an insulin pump. The information given here is based on her own personal experience and the listed references. More about Diana Maynard...

Created: March 2000; Last updated: Tuesday 5 June 2001


Other pages about pumps

[ Funding issues | Pros and cons of pumping | Diabetes UK on pump therapy | Pumps in the Republic of Ireland | What is an insulin pump? | Just like wearing a yoyo | Not controlled, but in control! | Rewriting the diabetes rulebook | To pump or not to pump? | Pumps in pregnancy | Using the insulin pump during pregnancy | Life on a pump | UK pump news | Which pump? | MiniMed | Disetronic | Animas | Books to help with diabetes | Other pump websites | My pump ]


Other pages about infusion sets

[ What is an insulin pump? | Pros and cons of pumping | Wearing a pump | Bad infusion sites and high bgs | Infusion sets | Books to help with diabetes | Using a DiaPort ]


Reader comments



HonCode This site subscribes to the HONcode principles of the Health On the Net Foundation

Insulin Pumpers and Insulin Pumpers UK are supported financially by voluntary contributions from members of its discussion groups and from all the principal insulin pump manufacturers.

editor@insulin-pumpers.org.uk www.insulin-pumpers.org.uk/prosandcons/index.shtml ©1999-2006 Insulin Pumpers